Codenotti, S., Asperti, M., Poli, M., Lorenzi, L., Pietrantoni, A., Cassandri, M., . . . Fanzani, A. (2025). Synthetic inhibition of SREBP2 and the mevalonate pathway blocks rhabdomyosarcoma tumor growth in vitro and in vivo and promotes chemosensitization. Molecular Metabolism, 92(102085-), . https://doi.org/10.1016/j.molmet.2024.102085
Chicago-referens (17:e uppl.)Codenotti, Silvia, Michela Asperti, Maura Poli, Luisa Lorenzi, Alberto Pietrantoni, Matteo Cassandri, Francesco Marampon, och Alessandro Fanzani. "Synthetic Inhibition of SREBP2 and the Mevalonate Pathway Blocks Rhabdomyosarcoma Tumor Growth in Vitro and in Vivo and Promotes Chemosensitization." Molecular Metabolism 92, no. 102085- (2025). https://doi.org/10.1016/j.molmet.2024.102085.
MLA-referens (9:e uppl.)Codenotti, Silvia, et al. "Synthetic Inhibition of SREBP2 and the Mevalonate Pathway Blocks Rhabdomyosarcoma Tumor Growth in Vitro and in Vivo and Promotes Chemosensitization." Molecular Metabolism, vol. 92, no. 102085-, 2025, https://doi.org/10.1016/j.molmet.2024.102085.
